So, as a primary care internist, I had my first experience of an Apple Watch potentially saving a patient's life. She'd had palpitations before, a normal EKG and Holter monitor, though she was not having symptoms during either of those tests. She decided to check an Apple Watch ECG while having symptoms, and brought that to her appointment. I was stunned to look at the tracing, which showed a period of prolonged ventricular tachcardia deteriorating into a brief period of ventricular fibrillation before going back into sinus rhythm.
While the ability to get the tracing likely saved her life, it's worrisome that the Apple Watch did not flag either the ventricular arrythmia or the fact that her heart rate was over 200 during the episode. It looks like the heart rate sensor is designed only to notice irregularity or a heart rate under 40, and the ECG is really only looking for atrial fibrillation. I can't figure out why this would be, given that an EKG or telemetry machine with markedly less sophisticated hardware can do so fairly reliably. The tracings are also sufficiently detailed to show things like long QT syndrome, but this also is not something flagged by the watch.
I am wondering if anyone has any insight into why Apple has not expanded analysis to evaluate beyond atrial fibrillation or bradycardia (low heart rate). There is incredible untapped potential here, if they would choose to use it.
Dave
While the ability to get the tracing likely saved her life, it's worrisome that the Apple Watch did not flag either the ventricular arrythmia or the fact that her heart rate was over 200 during the episode. It looks like the heart rate sensor is designed only to notice irregularity or a heart rate under 40, and the ECG is really only looking for atrial fibrillation. I can't figure out why this would be, given that an EKG or telemetry machine with markedly less sophisticated hardware can do so fairly reliably. The tracings are also sufficiently detailed to show things like long QT syndrome, but this also is not something flagged by the watch.
I am wondering if anyone has any insight into why Apple has not expanded analysis to evaluate beyond atrial fibrillation or bradycardia (low heart rate). There is incredible untapped potential here, if they would choose to use it.
Dave